Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v3-EN
Language English English
Date Updated 2018-01-09 2017-10-05
Drug Identification Number 00888354 00888354
Brand name IOPIDINE OPH SOL 1% IOPIDINE OPH SOL 1%
Common or Proper name APRACLONIDINE HCL APRACLONIDINE HCL
Company Name ESSENTIAL PHARMA SWITZERLAND GMBH ESSENTIAL PHARMA SWITZERLAND GMBH
Ingredients APRACLONIDINE APRACLONIDINE
Strength(s) 1% 1%
Dosage form(s) LIQUID LIQUID
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size (2 x 0.1mL) x 12 (2 x 0.1mL) x 12
ATC code S01EA S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-03 2017-10-03
Estimated end date 2018-01-24 Unknown
Actual end date 2018-01-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments